Generation of reactive oxygen species from the reaction of selenium compounds with thiols and mammary tumor cells
- PMID: 8382065
Generation of reactive oxygen species from the reaction of selenium compounds with thiols and mammary tumor cells
Abstract
Sodium selenite, sodium selenate, selenocystine and selenomethionine were tested for their abilities to generate superoxide by the oxidation of glutathione and other thiols in the absence and presence of cells of the human mammary tumor cell line HTB123/DU4475. Free radical generation was measured by lucigenin- or luminol-amplified chemiluminescence. In the absence of tumor cells, lucigenin-dependent chemiluminescence was observed from the reaction of selenite with the thiols glutathione, 2-mercaptoethanol and L-cysteine, but not with oxidized glutathione. Superoxide dismutase, catalase, and glutathione peroxidase all suppressed the observed chemiluminescence; but when these enzymes were heat inactivated they had little suppressive inhibition on chemiluminescence. Luminol-dependent chemiluminescence from the reaction of selenite with glutathione was much less than that observed by lucigenin-amplified chemiluminescence. In the presence of the HTB123/DU4475 mammary tumor cells, lucigenin-dependent chemiluminescence was observed from the reactions of selenite and selenocystine with glutathione which were 5 and 23 times greater than their respective reactions with glutathione in the absence of tumor cells. The enhanced chemiluminescence generated by selenite and selenocystine in the presence of the tumor cells was also suppressed by superoxide dismutase, catalase and glutathione peroxidase. These data suggest that a free radical, the superoxide anion (O2-), and H2O2 are produced from the reaction of selenite and selenocystine with glutathione. These free radical reactions may account for the toxicity of selenite and selenocystine in vitro in comparison to a near absence of acute tumor cell toxicity and superoxide generation by selenate and selenomethionine with thiols. Enhanced chemiluminescence in the presence of tumor cells may be an expression of cellular selenium metabolism and the capability of cells to form selenium metabolites that more easily oxidize glutathione and other thiols producing reactive free radicals and peroxides.
Similar articles
-
Effect of selenium compounds and thiols on human mammary tumor cells.Biol Trace Elem Res. 1991 Aug;30(2):145-62. doi: 10.1007/BF02990350. Biol Trace Elem Res. 1991. PMID: 1723886
-
Oxidation of glutathione and superoxide generation by inorganic and organic selenium compounds.Biofactors. 2007;31(1):55-66. doi: 10.1002/biof.5520310106. Biofactors. 2007. PMID: 18806309
-
Induction of the mitochondrial permeability transition by selenium compounds mediated by oxidation of the protein thiol groups and generation of the superoxide.Biochem Pharmacol. 2003 Dec 15;66(12):2301-11. doi: 10.1016/j.bcp.2003.08.021. Biochem Pharmacol. 2003. PMID: 14637188
-
Active oxygen generation as a possible mechanism of selenium toxicity.Biomed Environ Sci. 1997 Sep;10(2-3):333-9. Biomed Environ Sci. 1997. PMID: 9315327 Review.
-
Free radical generation by selenium compounds and their prooxidant toxicity.Biomed Environ Sci. 1997 Sep;10(2-3):260-70. Biomed Environ Sci. 1997. PMID: 9315319 Review.
Cited by
-
Cytotoxicity of Selenium Immunoconjugates against Triple Negative Breast Cancer Cells.Int J Mol Sci. 2018 Oct 26;19(11):3352. doi: 10.3390/ijms19113352. Int J Mol Sci. 2018. PMID: 30373175 Free PMC article.
-
Phenotype-dependent apoptosis signalling in mesothelioma cells after selenite exposure.J Exp Clin Cancer Res. 2009 Jun 29;28(1):92. doi: 10.1186/1756-9966-28-92. J Exp Clin Cancer Res. 2009. PMID: 19563663 Free PMC article.
-
Chemical form of selenium-containing metabolite in small intestine and liver of mice following orally administered selenocystine.Arch Toxicol. 1995;69(5):312-7. doi: 10.1007/s002040050176. Arch Toxicol. 1995. PMID: 7654135
-
A highly selective near-infrared fluorescent probe for imaging H2Se in living cells and in vivo.Chem Sci. 2016 Feb 1;7(2):1051-1056. doi: 10.1039/c5sc03471j. Epub 2015 Oct 28. Chem Sci. 2016. PMID: 28808528 Free PMC article.
-
Pharmacokinetics and Toxicity of Sodium Selenite in the Treatment of Patients with Carcinoma in a Phase I Clinical Trial: The SECAR Study.Nutrients. 2015 Jun 19;7(6):4978-94. doi: 10.3390/nu7064978. Nutrients. 2015. PMID: 26102212 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources